Repligen (RGEN) PT Raised to $210 at HSBC
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $167.60 -1.19%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
HSBC analyst Shubhangi Gupta raised the price target on Repligen (NASDAQ: RGEN) to $210.00 (from $170.00) while maintaining a Buy rating.
You May Also Be Interested In
- Sodexo (SW:FP) (SDXAY) PT Raised to EUR54 at Barclays
- Asana (ASAN) PT Raised to $9 at DA Davidson, Neutral Rating Maintained
- Hello Group (MOMO) PT Lowered to $8 at StoneX, Buy Rating Maintained
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
